4//SEC Filing
Scoggins Christopher J 4
Accession 0001179110-19-004719
CIK 0000001800other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:16 PM ET
Size
7.2 KB
Accession
0001179110-19-004719
Insider Transaction Report
Form 4
Scoggins Christopher J
Senior Vice President
Transactions
- Award
Common shares without par value
2019-04-01+8,278→ 33,578 total - Award
Option (right to buy)
2019-04-01$79.98/sh+43,388$3,470,172→ 43,388 totalExercise: $79.98From: 2020-04-01Exp: 2029-03-31→ Common shares (43,388 underlying)
Footnotes (2)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,462 on April 1, 2020, 14,463 on April 1, 2021, and 14,463 on April 1, 2022.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001772286
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:16 PM ET
- Size
- 7.2 KB